Mice lacking tartrate-resistant acid phosphatase (Acp 5) have disordered macrophage inflammatory responses and reduced clearance of the pathogen, Staphylococcus aureus

被引:94
作者
Bune, AJ
Hayman, AR
Evans, MJ
Cox, TM
机构
[1] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 2QQ, England
[2] Univ Cambridge, Wellcome CRC Inst Canc & Dev Biol, Cambridge, England
[3] Univ Cambridge, Dept Genet, Cambridge CB2 3EH, England
关键词
D O I
10.1046/j.1365-2567.2001.01145.x
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Tartrate-resistant acid phosphatase (TRAP) is a lysosomal di-iron protein of mononuclear phagocytes acid osteoclasts. Hitherto, no role Tor the enzyme in immunity has been identified; however, knockout mice lacking TRAP have a skeletal phenotype caused by an intrinsic osteoclast defect. To investigate a putative function for TRAP in macrophages (M phi). we investigated proinflammatory responses and systemic microbial clearance in knockout mice compared with age- and gender-matched congenic wild-type mice. Phorbol 12-myrislate 13-acetate (PMA)-stimulated and interferon-gamma (IFN-gamma)-induccd superoxide formation was enhanced in peritoneal M phi lacking TRAP: nitrite production in response to stimulation with lipopolysaccharide (LPS) and IFN-gamma was also increased. In addition, secretion of the proinflammatory cytokines, tumour necrosis factor-alpha (TNF-alpha), interleukin (IL)-1 beta and IL-12, was significantly greater in TRAP-deficient M phi when stimulated with LPS, with or without addition of either TNF-alpha or IFN-gamma. The activity of tartrate-sensitive (lysosomal) acid phosphatase was increased in M phi from the knockout mice but activities of the lysosomal hydrolases N-acetyl beta -glucosaminidase and acid beta -glucuronidase were unchanged, indicating selective activation of compensatory acid phosphatase activity. Evidence of impaired M phi function in vivo was obtained in TRAP knockout mice, which showed delayed clearance of the microbial pathogen, Staphylococcus aureus, after sublethal intraperitoneal inoculation. After microbial challenge, peritoneal exudates obtained from TRAP knockout mice had a reduced population or M phi. As peritoneal M phi and neutrophils lacking TRAP were able to phagocytose and kill S. aureus normally in vitro,, TRAP may directly or indirectly influence recruitment of M phi to sites of microbial invasion. Our study shows that TRAP participates in the inflammatory response of the M phi and influences effector signalling pathways in innate immunity.
引用
收藏
页码:103 / 113
页数:11
相关论文
共 51 条
  • [1] Impairment of mycobacterial immunity in human interleukin-12 receptor deficiency
    Altare, F
    Durandy, A
    Lammas, D
    Emile, JF
    Lamhamedi, S
    Le Deist, F
    Drysdale, P
    Jouanguy, E
    Döffinger, R
    Bernaudin, F
    Jeppsson, O
    Gollob, JA
    Meinl, E
    Segal, AW
    Fischer, A
    Kumararatne, D
    Casanova, JL
    [J]. SCIENCE, 1998, 280 (5368) : 1432 - 1435
  • [2] Eta-1 (osteopontin): An early component of type-1 (cell-mediated) immunity
    Ashkar, S
    Weber, GF
    Panoutsakopoulou, V
    Sanchirico, ME
    Jansson, M
    Zawaideh, S
    Rittling, SR
    Denhardt, DT
    Glimcher, MJ
    Cantor, H
    [J]. SCIENCE, 2000, 287 (5454) : 860 - 864
  • [3] DIFFERENTIATION OF RAT BONE-MARROW CELLS INTO MACROPHAGES UNDER THE INFLUENCE OF MOUSE L929 CELL SUPERNATANT
    BOLTZNITULESCU, G
    WILTSCHKE, C
    HOLZINGER, C
    FELLINGER, A
    SCHEINER, O
    GESSL, A
    FORSTER, O
    [J]. JOURNAL OF LEUKOCYTE BIOLOGY, 1987, 41 (01) : 83 - 91
  • [4] BRADBURY MG, 1993, CLIN EXP IMMUNOL, V94, P57
  • [5] STAPHYLOCOCCUS-AUREUS AND DERIVED EXOTOXINS INDUCE NUCLEAR FACTOR KAPPA-B-LIKE ACTIVITY IN MURINE BONE-MARROW MACROPHAGES
    BUSAM, K
    GIERINGER, C
    FREUDENBERG, M
    HOHMANN, HP
    [J]. INFECTION AND IMMUNITY, 1992, 60 (05) : 2008 - 2015
  • [6] Requirement for type 2 NO synthase for IL-12 signaling in innate immunity
    Diefenbach, A
    Schindler, H
    Röllinghoff, M
    Yokoyama, WM
    Bogdan, C
    [J]. SCIENCE, 1999, 284 (5416) : 951 - 955
  • [7] DING AH, 1988, J IMMUNOL, V141, P2407
  • [8] DREXLER HG, 1994, LEUKEMIA, V8, P359
  • [9] ECHETEBU ZO, 1987, CLIN CHEM, V33, P1832
  • [10] EKRYLANDER B, 1994, J BIOL CHEM, V269, P14853